G Medical Innovations Holdings Limited Accounts Payable

G Medical Innovations Holdings Limited's accounts payable stands at $4.7M as of December 2022. That compares with $2.3M in the prior-year period — up 99.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

G Medical Innovations Holdings Limited reported $4.7M in accounts payable versus $2.3M a year earlier — a 99.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $2.3M in the prior-year period — up 99.6% year over year. Sustained growth in accounts payable can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how G Medical Innovations Holdings Limited's accounts payable evolved across reporting periods, while the comparison chart places GMVD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, accounts payable is commonly used to spot outliers. G Medical Innovations Holdings Limited's reading of $4.7M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.